Several Drug-Related Bills Likely to Die with 112th Congress
By Mari Serebrov
Friday, August 31, 2012
As the House and Senate limp toward their lame duck session with a slate full of tax cut, budget and sequestration issues, it's likely that a number of drug-related bills still sitting in committee will die with the 112th Congress.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.